Atlas Trials

Treatment for Clostridium-difficile Infection With IMM529

Clinical trial NCT03065374 · TERMINATED

Trial details

NCT number
NCT03065374
Sponsor
Immuron Ltd.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Clostridium Difficile InfectionClostridium Difficile Infection Recurrence
Start date
2017-09-01
Primary completion
2019-11-07
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.